Isatin inhibits the invasion and metastasis of SH‑SY5Y neuroblastoma cells in vitro and in vivo

Hua,Yanan; Zhou,Na; Zhang,Jinyu; Zhang,Zheng; Li,Ning; Wang,Jun; Zheng,Wenxiang; Li,Xue; Wang,Fangling; Zhang,Li; Hou,Lin

doi:10.3892/ijo.2020.5144

Isatin inhibits the invasion and metastasis of SH‑SY5Y neuroblastoma cells in vitro and in vivo

Authors:
- Yanan Hua
- Na Zhou
- Jinyu Zhang
- Zheng Zhang
- Ning Li
- Jun Wang
- Wenxiang Zheng
- Xue Li
- Fangling Wang
- Li Zhang
- Lin Hou
View Affiliations

Affiliations: Department of Neurobiology of Basic Experimental Center Medical College, Medical Department, Qingdao University, Qingdao, Shandong 266021, P.R. China, Department of Biochemistry and Molecular Biology of Basic Experimental Center Medical College, Medical Department, Qingdao University, Qingdao, Shandong 266021, P.R. China, Experimental Center for Undergraduates of Pharmacy, School of Pharmacy, Qingdao University, Qingdao, Shandong 266021, P.R. China
Published online on: November 9, 2020 https://doi.org/10.3892/ijo.2020.5144
Pages: 122-132

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Indoline‑2,3‑dione or indole‑1H‑2,3‑dione, commonly known as isatin, is found in plants of genus Isatin and in Couropita guianancis aubl, and inhibits tumor cell proliferation through its antioxidant effects. The present study analyzed the effect of isatin on the malignant phenotype of neuroblastoma cells, and reported that isatin significantly inhibited neuroblastoma cell proliferation, invasion and migration in vitro in a dose‑dependent manner, and distant metastasis in tumor‑bearing mice. Mechanistically, isatin inhibited lysine‑specific histone demethylase (LSD)1 and reversed the blockade on p53, thereby activating the apoptotic pathway. The inhibitory effect of isatin on LSD1 may be mediated via direct binding and molecular docking or indirectly through the TGFβ/ERK/NF‑κB signaling pathway. Isatin also alleviated the renal and hepatic toxicity of cyclophosphamide in the tumor‑bearing mice, indicating its potential as a candidate drug as well as an adjuvant for treating metastatic neuroblastoma.

View Figures

View References

1	Vine KL, Matesic L, Locke JM, Ranson M and Skropeta D: Cytotoxic and anticancer activities of isatin and its derivatives: A comprehensive review from 2000-2008. Anticancer Agents Med Chem. 9:397–414. 2009. View Article : Google Scholar : PubMed/NCBI
2	Blažević T, Heiss EH, Atanasov AG, Breuss JM, Dirsch VM and Uhrin P: Indirubin and indirubin derivatives for counteracting proliferative diseases. Evid Based Complement Alternat Med. 2015:6540982015. View Article : Google Scholar
3	Medvedev A, Buneeva O and Glover V: Biological targets for isatin and its analogues: Implications for therapy. Biologics. 1:151–162. 2007.PubMed/NCBI
4	Premanathan M, Radhakrishnan S, Kulangiappar K, Singaravelu G, Thirumalaiarasu V, Sivakumar T and Kathiresan K: Antioxidant & anticancer activities of isatin (1H-indole-2,3-dione), isolated from the flowers of Couroupita guianensis Aubl. Indian J Med Res. 136:822–826. 2012.
5	Stafman LL and Beierle EA: Cell proliferation in neuroblastoma. Cancers (Basel). 8:132016. View Article : Google Scholar
6	Buhagiar A and Ayers D: Chemoresistance, cancer stem cells, and miRNA influences: The case for neuroblastoma. Anal Cell Pathol (Amst). 2015:1506342015.
7	Strother DR, London WB, Schmidt ML, Brodeur GM, Shimada H, Thorner P, Collins MH, Tagge E, Adkins S, Reynolds CP, et al: Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: Results of Children's Oncology Group study P9641. J Clin Oncol. 30:1842–1848. 2012. View Article : Google Scholar : PubMed/NCBI
8	Kreissman SG, Seeger RC, Matthay KK, London WB, Sposto R, Grupp SA, Haas-Kogan DA, Laquaglia MP, Yu AL, Diller L, et al: Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): A randomised phase 3 trial. Lancet Oncol. 14:999–1008. 2013. View Article : Google Scholar : PubMed/NCBI
9	Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, et al: Anti-GD2 antibody with GM-CSF, inter-leukin-2, and isotretinoin for neuroblastoma. N Engl J Med. 363:1324–1334. 2010. View Article : Google Scholar : PubMed/NCBI
10	Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F, Schleiermacher G, Park JR, et al: Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 33:3008–3017. 2016. View Article : Google Scholar
11	Hara J: Development of treatment strategies for advanced neuro-blastoma. Int J Clin Oncol. 17:196–203. 2012. View Article : Google Scholar : PubMed/NCBI
12	Mazalovska M and Kouokam JC: Plant-derived lectins as potential cancer therapeutics and diagnostic tools. Biomed Res Int. 2020:16313942020. View Article : Google Scholar : PubMed/NCBI
13	Han K, Zhou Y, Liu F, Guo Q, Wang P, Yang Y, Song B, Liu W, Yao Q, Teng Y and Yu P: Design, synthesis and in vitro cytotoxicity evaluation of 5-(2-carboxyethenyl)isatin derivatives as anticancer agents. Bioorg Med Chem Lett. 24:591–594. 2014. View Article : Google Scholar
14	Pakravan P, Kashanian S, Khodaei MM and Harding FJ: Biochemical and pharmacological characterization of isatin and its derivatives: From structure to activity. Pharmacol Rep. 65:313–335. 2013. View Article : Google Scholar : PubMed/NCBI
15	Watkins P, Clow A, Glover V, Halket J, Przyborowska A and Sandler M: Isatin, regional distribution in rat brain and tissues. Neurochem Int. 17:321–323. 1990. View Article : Google Scholar : PubMed/NCBI
16	Zou P and Koh HL: Determination of indican, isatin, indirubin and indigotin in Isatis indigotica by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom. 21:1239–1246. 2007. View Article : Google Scholar : PubMed/NCBI
17	Schulte JH, Lim S, Schramm A, Friedrichs N, Koster J, Versteeg R, Ora I, Pajtler K, Klein-Hitpass L, Kuhfittig-Kulle S, et al: Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: Implications for therapy. Cancer Res. 69:2065–2071. 2009. View Article : Google Scholar : PubMed/NCBI
18	Sakane C, Okitsu T, Wada A, Sagami H and Shidoji Y: Inhibition of lysine-specific demethylase 1 by the acyclic diterpenoid geranylgeranoic acid and its derivatives. Biochem Biophys Res Commun. 444:24–29. 2014. View Article : Google Scholar : PubMed/NCBI
19	Rotili D and Mai A: Targeting histone demethylases A new avenue for the fight against cancer. Genes Cancer. 2:663–679. 2011. View Article : Google Scholar : PubMed/NCBI
20	Wang Y, Zhang H, Chen Y, Sun Y, Yang F, Yu W, Liang J, Sun L, Yang X, Shi L, et al: LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell. 138:660–672. 2009. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2002. View Article : Google Scholar : PubMed/NCBI
22	Xue M, Liang H, Ji X, Liu Y and Sun T: Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology. Nutr Metab (Lond). 16:872019. View Article : Google Scholar
23	Soleimani A, Khazaei M, Ferns GA, Ryzhikov M, Avan A and Hassanian SM: Role of TGF-β signaling regulatory microRNAs in the pathogenesis of colorectal cancer. J Cell Physiol. Jan 26–2019.Epub ahead of print. View Article : Google Scholar
24	Rössler J, Breit S, Havers W and Schweigerer L: Vascular endothelial growth factor expression in human neuroblastoma: Up-regulation by hypoxia. Int J Cancer. 81:113–117. 1999. View Article : Google Scholar : PubMed/NCBI
25	Tamamura R, Nagatsuka H, Siar CH, Katase N, Naito I, Sado Y and Nagai N: Comparative analysis of basal lamina type IV collagen α chains, matrix metalloproteinases-2 and -9 expressions in oral dysplasia and invasive carcinoma. Acta Histochem. 115:113–119. 2013. View Article : Google Scholar
26	Lanza C, Galeazzi V, Carboni N, De Berardinis A, De Marino L, Barile A and Giovagnoni A: Neuroblastoma image-defined risk factors in adrenal neuroblastoma: Role of radiologist. Gland Surg. 8(Suppl 3): S168–S177. 2019. View Article : Google Scholar : PubMed/NCBI
27	Orr KE and McHugh K: The new international neuroblastoma response criteria. Pediatr Radiol. 49:1433–1440. 2019. View Article : Google Scholar : PubMed/NCBI
28	Belczacka I, Latosinska A, Siwy J, Metzger J, Merseburger AS, Mischak H, Vlahou A, Frantzi M and Jankowski V: Urinary CE-MS peptide marker pattern for detection of solid tumors. Sci Rep. 8:52272018. View Article : Google Scholar : PubMed/NCBI
29	Zage PE: Novel therapies for relapsed and refractory neuroblastoma. Children (Basel). 5:1482018.
30	Morandi F, Frassoni F, Ponzoni M and Brignole C: Novel immunotherapeutic approaches for neuroblastoma and malignant melanoma. J Immunol Res. 2018:80973982018. View Article : Google Scholar : PubMed/NCBI
31	Gencer N, Sonmez F, Demir D, Arslan O and Kucukislamoglu M: Synthesis, structure-activity relationships and biological activity of new isatin derivatives as tyrosinase inhibitors. Curr Top Med Chem. 14:1450–1462. 2014. View Article : Google Scholar : PubMed/NCBI
32	Ma Z, Hou L, Jiang Y, Chen Y and Song J: The endogenous oxindole isatin induces apoptosis of MCF7 breast cancer cells through a mitochondrial pathway. Oncol Rep. 32:2111–2117. 2014. View Article : Google Scholar : PubMed/NCBI
33	Lin H, Ju C, Zhang J, Song J, Ge Y and Wang Y: Antitumor effects of Isatin on human neuroblastoma cell line (SH-SY5Y) and the related mechanism. Eur J Pharmacol. 589:27–31. 2008. View Article : Google Scholar
34	Song J, Hou L, Ju C, Zhang J, Ge Y and Yue W: Isatin inhibits proliferation and induces apoptosis of SH-SY5Y neuroblastoma cells in vitro and in vivo. Eur J Pharmacol. 702:235–241. 2013. View Article : Google Scholar : PubMed/NCBI
35	Xu P, Hou L, Ju C, Zhang Z, Sun W, Zhang L, Song J, Lv Y, Liu L, Chen Z and Wang Y: Isatin inhibits the proliferation and invasion of SH-SY5Y neuroblastoma cells. Mol Med Rep. 13:2757–2762. 2016. View Article : Google Scholar : PubMed/NCBI
36	Zhang L, Sun W, Cao Y, Hou L and Wang X: Isatin inhibits the invasion of human neuroblastoma SH-SY5Y cells, based on microarray analysis. Mol Med Rep. 20:1700–1706. 2019.PubMed/NCBI
37	Schildhaus HU, Riegel R, Hartmann W, Steiner S, Wardelmann E, Merkelbach-Bruse S, Tanaka S, Sonobe H, Schüle R, Buettner R and Kirfel J: Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors. Hum Pathol. 42:1667–1675. 2011. View Article : Google Scholar : PubMed/NCBI
38	Khandanpour C and Möröy T: Growth factor independence 1 (Gfi1) as a regulator of p53 activity and a new therapeutical target for ALL. Oncotarget. 4:374–375. 2013. View Article : Google Scholar : PubMed/NCBI
39	Bandopadhyay M, Sarkar N, Datta S, Das D, Pal A, Panigrahi R, Banerjee A, Panda CK, Das C, Chakrabarti S and Chakravarty R: Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis. Infect Agent Cancer. 11:402016. View Article : Google Scholar : PubMed/NCBI
40	Sun W, Zhang L, Hou L, Ju C, Zhao S and Wei Y: Isatin inhibits SH-SY5Y neuroblastoma cell invasion and metastasis through MAO/HIF-1α/CXCR4 signaling. Anti Cancer Drugs. 28:645–653. 2017. View Article : Google Scholar
41	Itatani Y, Kawada K and Sakai Y: Transforming growth factor-β signaling pathway in colorectal cancer and its tumor microenvi-ronment. Int J Mol Sci. 20:58222019. View Article : Google Scholar
42	Lee HJ: The role of tripartite motif family proteins in TGF-β signaling pathway and cancer. J Cancer Prev. 23:162–169. 2018. View Article : Google Scholar
43	Xie F, Ling L, van Dam H, Zhou F and Zhang L: TGF-β signaling in cancer metastasis. Acta Biochim Biophys Sin (Shanghai). 50:121–132. 2018. View Article : Google Scholar